TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01873469 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03561402 — Predictive Biomarker (PRD): TLR2 mRNA
Genes: TLR2; TIL4
Study NCT03561402 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT03561402 — Predictive Biomarker (PRD): CCR1 mRNA
Genes: CCR1; CMKBR1; CMKR1; SCYAR1
Study NCT03561402 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03561402 — Predictive Biomarker (PRD): TLR2
Genes: TIL4; CD282
Study NCT05346107 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04643496 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04204980 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04105478 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01375075 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study NCT01375075 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01375075 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01073670 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00538083 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02104362 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02774993 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT00508235 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01860937 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00569257 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT01253876 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02016404 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00154947 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00154947 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study NCT02997241 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04348344 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01284569 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Interleukin 6 receptor alpha
Genes: IL6R
Study NCT01284569 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01804192 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04133207 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04133207 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04133207 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03996408 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00331435 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00220220 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03982134 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02171858 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01954927 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02730195 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03354143 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01795768 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT01795768 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT01938521 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00004358 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT01503242 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT01390545 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01390545 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04657237 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04657237 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02763943 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03495609 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03495609 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT03933722 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00639743 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04543305 — Predictive Biomarker (PRD): Induced myeloid leukemia cell differentiation protein Mcl-1
Genes: MCL1; BCL2L3
Study NCT00707122 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02272582 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT00813943 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT01209104 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study NCT04196998 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03352245 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02856425 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02856425 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02563002 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT00423488 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01559103 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03900598 — Predictive Biomarker (PRD): MALT1 mRNA
Genes: MALT1; MLT
Study NCT01199367 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01650012 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02489929 — Predictive Biomarker (PRD): CDA mRNA
Genes: CDA; CDD
Study NCT02489929 — Safety Biomarker (SAF): CDA
Genes: CDD
Study NCT00977301 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT02768610 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03145766 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02789345 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01104376 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT03161457 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01724645 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01724645 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01724645 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01724645 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02739048 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01103089 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03138239 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03999775 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04248621 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03526588 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01256385 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02897063 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00766753 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT02605525 — Predictive Biomarker (PRD): FCGR2B
Genes: CD32; CD32B; FcgammaRIIb; FcGRIIB
Study NCT01825772 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT00665314 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04598191 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01487876 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03449784 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02903004 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02903004 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT05107843 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT05107843 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT05107843 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study NCT05451420 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05451420 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03036488 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study NCT03036488 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04308486 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04775602 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02955472 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00277758 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02729961 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00327444 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00240305 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01782469 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02801448 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT00656890 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT02229201 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02229201 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT02229201 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01639326 — Safety Biomarker (SAF): UGT1A1
Genes: UGT1A
Study NCT03276169 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT03276169 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00977457 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT02921061 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04218565 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02372721 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03965000 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03986073 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02189044 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT01890187 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT04409847 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04409847 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04409847 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01426243 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01426243 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01466244 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01982968 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00056082 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02183753 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01287182 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01575041 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01724801 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01724801 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01368822 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02628509 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04477421 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT00053508 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00935090 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01391884 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT01391884 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02433431 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02459223 — Predictive Biomarker (PRD): EIF2AK1 mRNA
Genes: EIF2AK1; HRI; KIAA1369; PRO1362
Study NCT03001011 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03001011 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT02942173 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02828228 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02828228 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02278523 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT03820245 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01629199 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04561518 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT03156647 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT04060472 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study NCT04060472 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05217056 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00717236 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00824733 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01859793 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02065063 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT00114738 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01496157 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01496157 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT01496157 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT04557098 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT02055625 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01560182 — Predictive Biomarker (PRD): ARSA mRNA
Genes: ARSA
Study NCT01560182 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00001927 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT01937923 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02465580 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02465580 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01044849 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01999075 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01999075 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02295293 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02295293 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT02681328 — Predictive Biomarker (PRD): GSC mRNA
Genes: GSC
Study NCT00293332 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02917057 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT02917057 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02917057 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04271644 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04227275 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00735579 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT01871883 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT00232960 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05535595 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00853931 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04583358 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT02010970 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02010970 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT03235765 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05116943 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05116943 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04844996 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01637675 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT01583803 — Surrogate Endpoint (SUR): Bacterial count
Study NCT04296851 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT01967095 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04604132 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04604132 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT04604132 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT01874522 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study NCT04455308 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04120922 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04103411 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04821505 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00705978 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT01214486 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT01705691 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04232826 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04479319 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT02204904 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT02798926 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04134832 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT02073487 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01663194 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT03180892 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT03180892 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT03255252 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02799173 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT01509625 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00061763 — Predictive Biomarker (PRD): Liver iron
Study NCT00520247 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00587535 — Predictive Biomarker (PRD): Liver iron
Study NCT03557476 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03557476 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00002501 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00786708 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT00670709 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02484027 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01897909 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00065026 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02503683 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT04567836 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01007292 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00224562 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03018548 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03018548 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT03690154 — Predictive Biomarker (PRD): FN1 mRNA
Genes: FN1; FN
Study NCT02653703 — Predictive Biomarker (PRD): TRPA1 mRNA
Genes: TRPA1; ANKTM1
Study NCT04457583 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT00348140 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04222140 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT02379078 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02745184 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03027323 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03125928 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02245360 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT00237900 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02841605 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04349124 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03725423 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00005908 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT00005908 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01178814 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT01533272 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT04624061 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03490214 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04427514 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03421015 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT03421015 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39